The Patent Finder
US

Norepinephrine Compositions and Methods Therefor

US 10,159,657 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Jan 30, 2038 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Apr 10, 2018 as application 15/949,736 · Granted Dec 25, 2018
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
Jan 30, 2018
Ends no later than
Jan 30, 2038
Granted
Dec 25, 2018
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
15
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 30, 2018, when application 15/883,798, the earliest non-provisional in its chain, was filed (this one was filed Apr 10, 2018)Jan 30, 2038High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Jan 30, 2038Medium confidence

This family

US 10,226,436In force
Jan 2038
Jan 2038
US 10,159,657this patent
no later than Jan 2038
no later than Jan 2038
US 10,471,026In force
Jan 2038
Jan 2038
US 10,420,735In force
Jan 2038
Jan 2038
US 10,568,850In force
Jan 2038
Jan 2038
US 10,646,458In force
Jan 2038
Jan 2038
US 11,413,259In force
Jan 2038
Jan 2038
US 12,245,996In force
no later than Mar 2038
no later than Mar 2038
8 of 15 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 4, 2018
Reel 46080, frame 650
Nevakar LLCNevakar Inc.Change of Name
May 17, 2018
Reel 46180, frame 141
Yadav, Vivek; Garapati, Sriramya; Hingorani, Tushar; Ilitchev, Iouri V.; Akasapu, Prem Sagar; Soppimath, Kumaresh; Puri, NavneetNevakar Inc.Assignment of Assignor's Interest
Aug 13, 2021
Reel 57183, frame 825
Nevakar Inc.Nevakar Injectables Inc.Assignment of Assignor's Interest
Jan 18, 2023
Reel 62405, frame 329
Nevakar Injectables Inc.Oxford Finance LLCSecurity Interest
May 4, 2023
Reel 63545, frame 646
Nevakar Injectables Inc.H.I.G. Bio - Nevakar, L.P.Patent Security Agreement
May 9, 2023
Reel 63583, frame 948
Nevakar Injectables Inc.Novaquest Co.-Investment Fund IX, L.P.Security Interest
May 9, 2023
Reel 63588, frame 122
Oxford Finance LLCNovaquest Co.-Investment Fund X, L.P.Security Interest
May 15, 2026
Reel 74672, frame 415
Nevakar Injectables Inc.Nevakar Pharmaceuticals, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited